Patent ID: 7148246

Claim:
A compound of the formula I wherein Ring A is (C 6 )-cycloalkanediyl R 1 , R 2 are each independently H, F, Br, CF 3 , OCF 3 , (C 1 –C 6 )-alkyl, O—(C 1 –C 6 )-alkyl, SCF 3 , SF 5 , OCF 2 —CHF 2 , O-phenyl, OH, or NO 2 ; or R 1 and R 2 , taken together with the carbon atoms of the phenyl ring to which they are attached, form a fused, unsaturated or completely or partially saturated bicyclic (C 9 –C 12 )-aryl; R3 is H, CF 3 , (C 1 –C 6 )-alkyl, (C 1 –C 6 )-alkoxy, (C 3 –C 8 )-cycloalkyl or phenyl; X is (C 1 –C 6 )-alkanediyl, wherein one or more carbon atoms therein is optionally replaced by an oxygen atom; Y is (C 1 –C 6 )-alkanediyl or (C 1 –C 6 )-alkenediyl, wherein one or more carbon atoms therein is optionally replaced by O, CO, S, SO or SO 2 , and wherein said (C 1 –C 6 )-alkanediyl and (C 1 –C 6 )-alkenediyl groups are optionally substituted by OH; Ring B is a group selected from (a), (b) or (c): (a) phenyl optionally mono- or disubstituted by NO 2 , Cl, CN, (C 1 –C 6 )-alkyl or (C 1 –C 6 )-alkoxy (b) tetrazole (c) pyrrolidin-2-one wherein the pyrrolidinyl ring of said pyrrolidin-2-one group contains an additional nitrogen atom or a sulfur atom and is substituted by oxo or thioxo, and is optionally substituted on a nitrogen atom therein by R4; R4 is (C 1 –C 6 )-alkyl, phenyl or benzyl; and pharmaceutically acceptable salts thereof.